SCHEMBL1472901

SCHEMBL1472901

CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)Cc1cccc(C)c1C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCHE P06276 5/20 0.44
MAPT P10636 3/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
ACHE P22303 3/20 0.44
KCNH2 Q12809 4/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPK1 P28482 1/20 0.40
MCHR1 Q99705 1/20 0.39
DRD2 P14416 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
TP53 P04637 1/20 0.38
ICMT O60725 1/20 0.38
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1836537 1.00 BCHE (0.44) BCHEMAPTESR1ESR2ACHE
SCHEMBL6574866 1.00 BCHE (0.44) BCHEMAPTESR1ESR2ACHE
SCHEMBL9579609 1.00 BCHE (0.44) BCHEMAPTESR1ESR2ACHE
Hydrochloric Acid SCHEMBL6894361 0.98 MAPT (0.46) BCHEMAPTESR1ESR2ACHE
Water SCHEMBL6839087 0.98 BCHE (0.43) BCHEMAPTESR1ESR2ACHE
Hydrochloric Acid SCHEMBL6892141 0.98 MAPT (0.46) BCHEMAPTESR1ESR2ACHE
Water SCHEMBL6840837 0.98 BCHE (0.43) BCHEMAPTESR1ESR2ACHE
Hydrochloric Acid SCHEMBL4137773 0.98 MAPT (0.46) BCHEMAPTESR1ESR2ACHE
Hydrochloric Acid SCHEMBL6894428 0.98 MAPT (0.46) BCHEMAPTESR1ESR2ACHE
Hydrochloric Acid SCHEMBL3131665 0.98 MAPT (0.46) BCHEMAPTESR1ESR2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311873-B1 M-CSF-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF NOVARTIS VACCINES & DIAGNOSTICS INC (US) 2018-08-29 EP claimed
EP-2676676-B1 Recombinant viral vectors INT AIDS VACCINE INITIATIVE (US) 2017-05-03 EP claimed
EP-1812149-B1 SEMIPERMEABLE COMPOSITE MEMBRANE, PRODUCTION PROCESS THEREOF AND TREATMENT METHOD FOR BORON-CONTAINING WATER TORAY INDUSTRIES (JP) 2013-06-12 EP claimed
EP-0764676-B1 Method of preparing polycarbonate-polysiloxane block copolymers GEN ELECTRIC (US) 2004-04-28 EP claimed
EP-0842248-B1 BLOOMING TYPE, HARD SURFACE CLEANING AND/OR DISINFECTING COMPOSITIONS RECKITT BENCKISER INC (US) 2003-05-21 EP claimed
WO-2020258699-A1 ANTI-FINGERPRINT TAPE FOR WIRELESS CHARGER 浙江欧仁新材料有限公司 2020-12-30 WO disclosed
WO-2019033455-A1 PRINTING AND DYEING AUXILIARY 南通中润纺织印染有限公司 2019-02-21 WO disclosed
WO-2019033456-A1 PRINTING AND DYEING AUXILIARY FOR FABRIC 南通中润纺织印染有限公司 2019-02-21 WO disclosed
US-7932324-B2 Block polymers and cosmetic compositions and processes comprising them L'OREAL (FR) 2011-04-26 US disclosed
US-7915347-B2 Block polymers and cosmetic compositions and processes comprising them L'OREAL S.A. (FR) 2011-03-29 US disclosed
US-7803877-B2 Block polymers and cosmetic compositions and processes comprising them L'OREAL S.A. (FR) 2010-09-28 US disclosed
US-20080014158-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them L'OREAL 2008-01-17 US disclosed
US-20080014234-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them L'OREAL 2008-01-17 US disclosed
US-20080014235-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them L'OREAL 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080014235-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them FANCI, GDI2, TBCB BCHE 3233/4885MAPT 1240/4885ESR1 4479/4885
US-20080014234-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them FANCI, GDI2, TBCB BCHE 3233/4885MAPT 1240/4885ESR1 4479/4885
US-20080014158-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them FANCI, GDI2, TBCB BCHE 3233/4885MAPT 1240/4885ESR1 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.